Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 2827721

Thyroid function in trophoblastic disease.

M Lemon·B R Bevan·T C Li·G W Pennington
View original source ↗Export metadata ↓

Abstract

Human chorionic gonadotrophin (hCG) levels and thyroid function were monitored in 44 patients receiving chemotherapy for treatment of trophoblastic disease. We observed a strong correlation between hCG and thyroid stimulating hormone (TSH) concentrations measured by radioimmunoassay, and this appears to be due to cross-reactivity between hCG and the anti-TSH antibody used. The concentration of thyroid hormones was little affected by the raised levels of TSH or hCG, except when the concentration of the latter rose to high levels, usually above 100,000 i.u./l. The possible mechanisms of thyroid homeostasis in trophoblastic disease are considered.

Explore related subjects

Antineoplastic Combined Chemotherapy ProtocolsChorionic GonadotropinFemaleHumansPregnancyThyroid GlandThyrotropinThyroxineTriiodothyronineTrophoblastic NeoplasmsUterine NeoplasmsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Lemon, B R Bevan, T C Li, G W Pennington. 1987. Thyroid function in trophoblastic disease.. https://doi.org/10.1111/j.1471-0528.1987.tb02294.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Adjuvant therapy for primary breast cancer in a female patient affected by autoimmune liver disease: does it cure breast cancer and primary biliary cirrhosis?

Polychemotherapy (CMF or CMF-like regimens) is the treatment of choice in premenopausal breast cancer patients with 1-3 positive nodes. In clinical practice, patients with abnormal biochemical tests of liver function are usually excluded from this potentially curative methotrexate-containing regimen in order to avoid worsening of hepatic damage. On the other hand, recent reports have shown a beneficial effect of methotrexate in a particular autoimmune liver disease such as primary biliary cirrhosis. We discuss the case of a female patient with breast cancer and primary biliary cirrhosis whose biochemical tests of liver function and the titer of antimitochondrial antibody persistently improved after treatment with 3 cycles of CMF. In conclusion, we suggest that the CMF regimen is potentially useful in patients with breast cancer and primary biliary cirrhosis.

Antineoplastic Combined Chemotherapy Protocols↗